EZH2 and sarcoma: Previous research indicated that EZH2 is significantly upregulated in various types of sarcoma, including Ewing sarcoma [12] and synovial sarcoma [13], where its overexpression is associated with aggressive tumour behaviour and poor prognosis [14].